STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

ARDX ARDELYX INCORPORATED StockScouter® Report

2

StockScouter® Score

ARDELYX INCORPORATED, a small cap growth company in the healthcare sector, is expected to underperform the market over the next six months with slightly higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Shares are under accumulation by financial institutions. Marginally positive for a small company like ARDX

 

Concerns

  • The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative
  • The multi-period measure of relative price change and consistency is well below average. Negative
  • Moving average analysis for ARDX suggests weak price movement over the medium term. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, growth stocks will be in favor, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 80% done.
Progress: 20% done.
Low
High

Core Model Grades

D
C
D
F

Previous Ratings

4
5
3